Jaguar Health (JAGX) said Wednesday it has agreed to the purchase and sale of 246,306 shares of common stock at a price of $6.09 per share in a registered direct offering.
In a simultaneous private placement, the company said it agreed to issue unregistered warrants to purchase up to 492,612 shares at an exercise price of $5.84 per share.
The offering is expected to close Thursday, the company said.
The proceeds to the company from the offering are expected to be about $1.5 million, which the company said it expects to use for general corporate purposes.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.